HologicFRA:HO1 57 Days Payable is 38.96 as of Dec. 2025, which is 1% below its 10-year median of 39.30. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Hologic ranks worse than 77.11% on this metric.
Hologic's average Accounts Payable for the
three
months ended in Dec. 2025 was €168 Mil. Hologic's Cost of Goods Sold for the
three
months ended in Dec. 2025 was €394 Mil.
Hence, Hologic's Days Payable for the
three
months ended in Dec. 2025 was 38.96.
The historical rank and industry rank for Hologic's Days Payable or its related term are showing as below:
FRA:HO1'
s Days Payable Range Over the Past 10 Years
Min: 31.47 Med: 39.3 Max: 43.05
Current: 37.64
During the past 13 years, Hologic's highest Days Payable was 43.05. The lowest was 31.47. And the median was 39.30.
FRA:HO1's Days Payable is ranked worse than 77.11% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:HO1: 37.64
Hologic's Days Payable
declined
from Dec. 2024 (44.35) to Dec. 2025 (38.96).
It may suggest that Hologicaccelerated paying its suppliers.
Hologic Days Payable Related Terms
Hologic Days Payable Historical Data
* Premium members only.
The historical data trend for Hologic's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HO1 vs WST, COO, ALGN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Hologic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's Days Payable distribution charts can be found below:
* The bar in red indicates where Hologic's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Hologic's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (FRA:HO1) has a Days Payable of 38.96 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hologic and its competitors. This is near median its historical median of 39.30. Over the past decade, Hologic's Days Payable has ranged from 31.47 to 43.05. According to the industry distribution chart, Hologic ranks #613 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 77.1%.
Is Hologic's Days Payable too high?
Hologic's current Days Payable of 38.96 is near median its 10-year median of 39.30. Over the past 10 years, this metric has ranged from a low of 31.47 to a high of 43.05. The Medical Devices & Instruments industry median Days Payable is 68.07. Hologic's value of 38.96 is 42.8% below this industry median. Based on the distribution chart, Hologic ranks #613 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's Days Payable compare to WST and COO?
According to the Medical Devices & Instruments industry distribution chart, Hologic ranks #613 out of 795 companies for Days Payable. This places Hologic in the lower half of its industry. The industry median Days Payable is 68.07. Hologic's value of 38.96 is 42.8% below this benchmark. Historically, Hologic's own Days Payable has ranged from 31.47 to 43.05 over the past decade. While the company's 10-year median is 39.30 vs. the industry median of 68.07, Hologic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current Days Payable of 38.96 is 42.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current Days Payable is 38.96, which is near median its own 10-year median of 39.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current Days Payable of 38.96. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current Days Payable is 38.96, which is near median its 10-year median of 39.30 and 42.8% below the Medical Devices & Instruments industry median of 68.07. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hologic (FRA:HO1), the current Days Payable is 38.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (FRA:HO1) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.
Key valuation signals for FRA:HO1:
Days Payable: 38.96 (near median its 10-year median of 39.30)
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
Industry Position: 42.8% below the Medical Devices & Instruments median (#613 of 795)
No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for FRA:HO1
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HO1 has been successfully added to your 
